Medicare Enrolled
Dr. Roberto Salcedo, MD
Optician · Hermitage, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Salcedo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Salcedo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Salcedo
Dr. Roberto Salcedo is an optician specialist in Hermitage, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Salcedo performed 854 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Salcedo received a total of $80,345 from 65 pharmaceutical and/or device companies across 1378 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Salcedo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 36% volume in PA
$80,345 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗854
Medicare services
Top 36% in PA for optician
Not available
Unique patients (not deduplicated)
$124
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
248 | $84 | $143 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
168 | $129 | $193 |
| New patient office visit, complex (60-74 min) | 102 | $152 | $278 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
97 | $286 | $523 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
91 | $73 | $150 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
48 | $67 | $135 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
36 | $185 | $370 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
27 | $9 | $20 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
19 | $122 | $260 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
18 | $71 | $240 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$80,345
Total received (2018-2024)
Avg $11,478/year across 7 years
Top 4% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
1,378
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$17,498
2023
$8,465
2022
$11,466
2021
$13,604
2020
$7,511
2019
$13,071
2018
$8,729
Payments by company (2024)
GENZYME CORPORATION
$13,149
MDD US Operations, LLC
$441
Neurocrine Biosciences, Inc.
$314
ABBVIE INC.
$276
Biogen, Inc.
$265
ARGENX US, INC.
$216
UCB, Inc.
$213
MITSUBISHI TANABE PHARMA AMERICA, INC.
$208
Genentech USA, Inc.
$202
SK Life Science, Inc.
$192
Celgene Corporation
$181
Alexion Pharmaceuticals, Inc.
$179
Teva Pharmaceuticals USA, Inc.
$177
JAZZ PHARMACEUTICALS INC.
$168
Novartis Pharmaceuticals Corporation
$159
Amgen Inc.
$142
ACADIA Pharmaceuticals Inc
$142
Genentech, Inc.
$109
Otsuka America Pharmaceutical, Inc.
$106
Grifols USA, LLC
$90
Lilly USA, LLC
$83
Lundbeck LLC
$80
Amneal Pharmaceuticals LLC
$70
Sumitomo Pharma America, Inc.
$57
Acorda Therapeutics, Inc
$54
Neurelis, Inc.
$42
PFIZER INC.
$35
Kyowa Kirin, Inc.
$34
EMD Serono, Inc.
$31
Boston Scientific Corporation
$24
Eisai Inc.
$24
Vanda Pharmaceuticals Inc.
$23
GE HEALTHCARE
$13
Top 3 companies account for 79.5% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$49,188
CATALYST PHARMACEUTICALS, INC.
$3,867
Adamas Pharmaceuticals, Inc.
$3,774
Biogen, Inc.
$2,494
UCB, Inc.
$2,313
Teva Pharmaceuticals USA, Inc.
$2,302
Genentech USA, Inc.
$1,631
Novartis Pharmaceuticals Corporation
$1,071
Amgen Inc.
$964
Lilly USA, LLC
$793
EMD Serono, Inc.
$751
Celgene Corporation
$728
ACADIA Pharmaceuticals Inc
$716
MDD US Operations, LLC
$690
SK Life Science, Inc.
$664
Neurelis, Inc.
$621
MITSUBISHI TANABE PHARMA AMERICA, INC.
$579
ARGENX US, INC.
$540
Alexion Pharmaceuticals, Inc.
$487
AbbVie Inc.
$431
Neurocrine Biosciences, Inc.
$377
ABBVIE INC.
$362
PFIZER INC.
$333
Acorda Therapeutics, Inc
$331
Janssen Pharmaceuticals, Inc
$310
NOVARTIS PHARMACEUTICALS CORPORATION
$306
Biohaven Pharmaceuticals, Inc.
$262
US WorldMeds, LLC
$250
Amneal Pharmaceuticals LLC
$242
Lundbeck LLC
$236
Otsuka America Pharmaceutical, Inc.
$215
JAZZ PHARMACEUTICALS INC.
$189
Allergan, Inc.
$166
Biohaven Pharmaceutical Holding Company Ltd.
$163
Sumitomo Pharma America, Inc.
$149
Jazz Pharmaceuticals Inc.
$148
Banner Life Sciences, LLC
$136
EISAI INC.
$119
Genentech, Inc.
$109
Eisai Inc.
$107
E.R. Squibb & Sons, L.L.C.
$101
Avanir Pharmaceuticals, Inc.
$96
Abbott Laboratories
$93
Grifols USA, LLC
$90
Kyowa Kirin, Inc.
$85
BANNER LIFE SCIENCES, LLC
$83
Impax Laboratories, Inc.
$71
Harmony Biosciences LLC
$66
Mitsubishi Tanabe Pharma America, Inc.
$66
LivaNova USA, Inc.
$54
Amylyx Pharmaceuticals, Inc.
$48
AstraZeneca Pharmaceuticals LP
$38
Bayer HealthCare Pharmaceuticals Inc.
$37
Avion Pharmaceuticals
$36
Vertical Pharmaceuticals, LLC
$34
Zyla Life Sciences
$30
GE HealthCare
$27
Supernus Pharmaceuticals, Inc.
$27
SANOFI-AVENTIS U.S. LLC
$25
Boston Scientific Corporation
$24
GE HEALTHCARE
$23
Vanda Pharmaceuticals Inc.
$23
Strongbridge US INC.
$21
TG THERAPEUTICS, INC.
$17
Allergan Inc.
$16
Top 3 companies account for 70.7% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · Cenobamate · DISEASE STATE · DUOPA · Dhivy · EMGALITY · EPIDIOLEX · EVUSHELD · Enspryng · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Gocovri · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · LEMTRADA · LUMIZYME · Leqembi · MAYZENT · MS DISEASE STATE · MYOBLOC · Mavenclad · NAMZARIC · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · OSMOLEX ER · Ocrevus · Ocrevus Zunovo · Ozanimod · PAXLOVID · PIPELINE-MS · PONVORY · Ponvory · QULIPTA · RADICAVA · RELEXXII · RELYVRIO · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · XARELTO · XCOPRI · Xadago · ZEPOSIA · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
97
County median income
$60,614
Nearest hospital to ZIP centroid (approximate)
SHARON REGIONAL MEDICAL CENTER
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Salcedo is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Salcedo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Salcedo performed 248 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Salcedo receive payments from pharmaceutical companies?
Yes. Dr. Salcedo received a total of $80,345 from 65 companies across 1,378 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Salcedo's costs compare to other opticians in Hermitage?
Dr. Salcedo's average Medicare payment per service is $124. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Salcedo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Hermitage
Browse opticians in Hermitage ranked by procedure volume and transparency data.
Highest volume
Top Opticians in PA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in PA
Which PA opticians receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
CATALYST PHARMACEUTICALS, INC. Payments to Doctors
See all physicians who received payments from CATALYST PHARMACEUTICALS, INC.
By company
Adamas Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Adamas Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology